Ernexa Therapeutics Inc. · NASDAQ:ERNA
Ernexa Therapeutics Inc. shareholders
As of Sep 30, 2026, 14 institutions reported holding Ernexa Therapeutics Inc., 3.2% of its shares. Largest: Corient Private Wealth LP, Geode Capital and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Ernexa Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| Corient Private Wealth LP | 17,461 | 1.0% | new | Nov 16, 2026 |
| Geode Capital | 16,077 | 0.95% | new | Nov 6, 2026 |
| Vanguard | 14,020 | 0.83% | no change | Nov 13, 2026 |
| Tradewinds Capital Management, LLC | 4,609 | 0.27% | +4,248 | Oct 23, 2026 |
| Tower Research Capital LLC (TRC) | 1,552 | 0.09% | new | Nov 16, 2026 |
| Morgan Stanley | 200 | 0.01% | new | Nov 13, 2026 |
| Citigroup Inc | 102 | <0.01% | new | Nov 4, 2026 |
| BlackRock | 33 | <0.01% | no change | Nov 13, 2026 |
| UBS | 19 | <0.01% | new | Nov 10, 2026 |
| Assetmark, Inc | 5 | <0.01% | no change | Oct 21, 2026 |